IGFBP1 acts as a proangiogenic factor contributing to HCV-associated with hepatocellular carcinoma pathogenesis [70] and that elevated IGFBP1 expression is associated with hematogenous metastasis and poor outcome of gastric cancer [71]. Here, IGFBP1 is linked to gastric cancer.